Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Nihon Jinzo Gakkai Shi ; 44(8): 817-22, 2002 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-12607972

RESUMO

We report here two interesting cases of systemic lupus erythematosus(SLE) accompanied by antiphospholipid syndrome nephropathy(APSN). These cases satisfied the criteria for SLE established by the American College of Rheumatology 1997 and also satisfied the criteria for antiphospholipid syndrome (APS) established by the Sapporo International Workshop of APS 1998. Both cases had high blood pressure with elevated plasma renin activity, proteinuria and renal dysfunction. Their biopsied renal specimens showed the characteristic findings for APSN, such as mesangial proliferation, double contours, thickening of the capillary loops, and intimal hyperplasia, but there was no evidence for immune complexes in the glomeruli, which were examined by the indirect immunofluorescence methods and the electron microscopy method. These results indicated that their renal dysfunction was caused by APSN, but not by immune complex nephritis. In addition to treatment with prednisolone, they were administered anticoagulants(warfarin, or aspirin, or heparin) for APSN and an angiotensin II receptor blocker, candesartan, for the hypertension. Subsequently, their conditions recovered with the improvement of renal function and hypertension. Our experiences suggest that anticoagulant therapy in addition to corticosteroids offers advantages in the treatment of patients with SLE accompanied by APSN and renal dysfunction.


Assuntos
Síndrome Antifosfolipídica/complicações , Nefropatias/etiologia , Lúpus Eritematoso Sistêmico/complicações , Adulto , Antagonistas de Receptores de Angiotensina , Anticoagulantes/uso terapêutico , Complexo Antígeno-Anticorpo/metabolismo , Anti-Hipertensivos/uso terapêutico , Síndrome Antifosfolipídica/tratamento farmacológico , Síndrome Antifosfolipídica/patologia , Benzimidazóis/uso terapêutico , Compostos de Bifenilo , Feminino , Humanos , Hipertensão/tratamento farmacológico , Hipertensão/etiologia , Nefropatias/tratamento farmacológico , Glomérulos Renais/metabolismo , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Pessoa de Meia-Idade , Prednisolona/uso terapêutico , Tetrazóis/uso terapêutico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA